Table 3 The genomic profiles of SBC detected by NGS have been reported in the literature
Author | year | cases | ETV6- NTRK3 fusion | Other variant gene | prognosis | |
|---|---|---|---|---|---|---|
Krings et al [5] | 2017 | 1 | + | IRS2 | NA | |
2 | + | - | NA | |||
3 | + | SOX9 | NA | |||
4 | + | SMARCA4 | NA | |||
5 | + | - | NA | |||
6 | + | CHD4 | NA | |||
7 | + | RASA1 | NA | |||
8 | + | - | NA | |||
9 | + | - | NA | |||
Hoda et al [18] | 2019 | 1primary lesion | + | 16p13.3 amplification | 12 months Recurrence and metastasis | |
1metastasis lesion | + | TERT CDKN2A | ANED | |||
2primary lesion | + | - | 45months Recurrence and metastasis | |||
2metastasis lesion | + | 9p21.3 loss | ANED | |||
Maund et al [12] | 2022 | 7 cases | + | FGF4, FGF3, TERT, EMSY, CDH1, ZNF703, PTEN, PIK3CA, PIK3C2B, MDM4, MCL1 | NA | |
2 cases | - | LMNA ‐ NTRK1 | NA | |||
2 cases | - | TPM3 ‐ NTRK1 | NA | |||
Chen et al [2] | 2022 | 2 cases | + | UGT1A1 | NA | |